Comorbidity between Type 2 Diabetes and Depression in the Adult Population: Directions of the Association and Its Possible Pathophysiological Mechanisms

International Journal of Endocrinology

Volumn 2015, Issue , 2015, Pages

  Berge, Line Iden ^a,b   Riise, Trond ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; INSULIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AUTONOMIC NERVOUS SYSTEM; BRAIN FUNCTION; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EARLY LIFE STRESS; EDUCATIONAL STATUS; EPIGENETICS; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; GLYCEMIC CONTROL; HIGH RISK POPULATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; NEUROANATOMY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SOCIAL STATUS; STRESS; SYSTEMATIC REVIEW (TOPIC);

EID: 84942863331     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2015/164760     Document Type: Review

References (67)

1. A. R. Feinstein, "The pre-therapeutic classification of co-morbidity in chronic disease, " Journal of Chronic Diseases, vol. 23, no. 7, pp. 455-468, 1970.
2. A. G. Ording and H. T. Sorensen, "Concepts of comorbidities, multiple morbidities, complications, and their clinical epidemiologic analogs, " Clinical Epidemiology, vol. 5, no. 1, pp. 199-203, 2013.
3. L. I. Berge, Depression and Migraine Comorbid to Diabetes. Epidemiological StudiesUtilizingData fromtheNorwegian Prescription Database and the Hordaland Health Stusy, University of Bergen, Bergen, Norway, 2014.
4. International Diabetes Federation, Atlas, International Diabetes Federation, 5th edition, 2013.
5. E. Bromet, L. H. Andrade, I. Hwang et al., "Cross-national epidemiology of DSM-IV major depressive episode, " BMC Medicine, vol. 9, article 90, 2011.
6. National Institute of Health Meterics Evaluation, "Global Burden of Disease, " 2013.
7. S. Moussavi, S. Chatterji, E. Verdes, A. Tandon, V. Patel, and B. Ustun, "Depression, chronic diseases, and decrements in health: results from theWorldHealth Surveys, "The Lancet, vol. 370, no. 9590, pp. 851-858, 2007.
8. S. H. Golden, M. Lazo, M. Carnethon et al., "Examining a bidirectional association between depressive symptoms and diabetes, " Journal of the AmericanMedical Association, vol. 299, no. 23, pp. 2751-2759, 2008.
9. B. Mezuk, W. W. Eaton, S. Albrecht, and S. H. Golden, "Depression and type 2 diabetes over the lifespan: Ameta-analysis, " Diabetes Care, vol. 31, no. 12, pp. 2383-2390, 2008.
10. A. Pan, M. Lucas, Q. Sun et al., "Bidirectional association between depression and type 2 diabetes mellitus in women, " Archives of Internal Medicine, vol. 170, no. 21, pp. 1884-1891, 2010.
11. B. N. Renn, L. Feliciano, and D. L. Segal, "The bidirectional relationship of depression and diabetes: A systematic review, " Clinical Psychology Review, vol. 31, no. 8, pp. 1239-1246, 2011.
12. S. E. Huether and K. L. McCance, Understanding Pathophysiology, Elsevier, 5th edition, 2013.
13. S. Champaneri, G. S. Wand, S. S. Malhotra, S. S. Casagrande, and S. H. Golden, "Biological basis of depression in adults with diabetes, " Current Diabetes Reports, vol. 10, no. 6, pp. 396-405, 2010.
14. S. H. Golden, "A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus, " Current Diabetes Reviews, vol. 3, no. 4, pp. 252-259, 2007.
15. M. S. Katon, Depression and Diabetes, World Psychiatric Association, Wiley-Blackwell, 2010.
16. J. K. Rustad, D. L. Musselman, and C. B. Nemeroff, "The relationship of depression and diabetes: pathophysiological and treatment implications, " Psychoneuroendocrinology, vol. 36, no. 9, pp. 1276-1286, 2011.
17. J. F. Scherrer, H. Xian, P. J. Lustman et al., "A test for common genetic and environmental vulnerability to depression and diabetes, " Twin Research and Human Genetics, vol. 14, no. 2, pp. 169-172, 2011.
18. A. Nanri, "Nutritional epidemiology of type 2 diabetes and depressive symptoms, " Journal of Epidemiology, vol. 23, no. 4, pp. 243-250, 2013.
19. J. P. Reis, C. M. Loria, P. D. Sorlie, Y. Park, A. Hollenbeck, and A. Schatzkin, "Lifestyle factors and risk for new-onset diabetes: A population-based cohort study, " Annals of Internal Medicine, vol. 155, no. 5, pp. 292-299, 2011.
20. M. Berk, J. Sarris, C. E. Coulson, and F. N. Jacka, "Lifestylemanagement of unipolar depression, " Acta Psychiatrica Scandinavica. Supplementum, no. 443, pp. 38-54, 2013.
21. H. Alastalo, K. Räikkönen, A.-K. Pesonenet al., "Cardiovascular health of Finnish war evacuees 60 years later, " Annals of Medicine, vol. 41, no. 1, pp. 66-72, 2009.
22. A.-K. Pesonen, K. Räikkönen, K. Heinonen, E. Kajantie, T. Forsén, and J. G. Eriksson, "Depressive symptoms in adults separated from their parents as children: A natural experiment during World War II, " American Journal of Epidemiology, vol. 166, no. 10, pp. 1126-1133, 2007.
23. E. Agardh, P. Allebeck, J. Hallqvist, T. Moradi, and A. Sidorchuk, "Type 2 diabetes incidence and socio-economic position: A systematic review and meta-analysis, " International Journal of Epidemiology, vol. 40, no. 3, Article ID dyr029, pp. 804-818, 2011.
24. S. E. Gilman, I. Kawachi, G. M. Fitzmaurice, and S. L. Buka, "Socioeconomic status in childhood and the lifetime risk of major depression, " International Journal of Epidemiology, vol. 31, no. 2, pp. 359-367, 2002.
25. A. Menke, K. F. Rust, J. Fradkin, Y. J. Cheng, and C. C. Cowie, "Associations between trends in race/ethnicity, aging, and body mass index with diabetes prevalence in the United States: A series of cross-sectional studies, " Annals of Internal Medicine, vol. 161, no. 5, pp. 328-335, 2014.
26. F. S. Luppino, L. M. deWit, P. F. Bouvy et al., "Overweight, obesity, and depression: A systematic review and meta-analysis of longitudinal studies, " Archives of General Psychiatry, vol. 67, no. 3, pp. 220-229, 2010.
27. National Health Services England, 2015, http://www. nhs. uk/ Conditions/Corticosteroid-(drugs)/Pages/Sideeffects. Aspx.
28. E. Charmandari, C. Tsigos, and G. Chrousos, "Endocrinology of the stress response, " Annual Review of Physiology, vol. 67, pp. 259-284, 2005.
29. P. H. Black, "Stress and the inflammatory response: A review of neurogenic inflammation, " Brain, Behavior, and Immunity, vol. 16, no. 6, pp. 622-653, 2002.
30. G. P. Chrousos and P. W. Gold, "The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis, " The Journal of the American Medical Association, vol. 267, no. 9, pp. 1244-1252, 1992.
31. I. J. Elenkov, R. L. Wilder, G. P. Chrousos, and E. S. Vizi, "The sympathetic nerve-an integrative interface between two supersystems: The brain and the immune system, " Pharmacological Reviews, vol. 52, no. 4, pp. 595-638, 2000.
32. M. Maes, C. Song, A. Lin et al., "The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety, " Cytokine, vol. 10, no. 4, pp. 313-318, 1998.
33. M. U. Goebel, P. J. Mills, M. R. Irwin, and M. G. Ziegler, "Interleukin-6 andtumor necrosis factor-alphaproductionafter acute psychological stress, exercise, and infused isoproterenol: differential effects and pathways, " PsychosomaticMedicine, vol. 62, no. 4, pp. 591-598, 2000.
34. C. L. Raison, L. Capuron, and A. H. Miller, "Cytokines sing the blues: inflammation and the pathogenesis of depression, " Trends in Immunology, vol. 27, no. 1, pp. 24-31, 2006.
35. R. F. Grimble, "Inflammatory status and insulin resistance, " Current Opinion in Clinical Nutrition andMetabolic Care, vol. 5, no. 5, pp. 551-559, 2002.
36. S. Stringhini, G. D. da Batty, P. Bovet et al., "Association of lifecourse socioeconomic status with chronic inflammation and type 2 diabetes risk: TheWhitehall II prospective cohort study, " PLoS Medicine, vol. 10, no. 7, Article IDe1001479, 2013.
37. R. H. Belmaker and G. Agam, "Major depressive disorder, " The NewEngland Journal ofMedicine, vol. 358, no. 1, pp. 55-68, 2008.
38. M. A. H. Rot, S. J. Mathew, and D. S. Charney, "Neurobiological mechanisms in major depressive disorder, " Canadian Medical Association Journal, vol. 180, no. 3, pp. 305-313, 2009.
39. E. R. de Kloet, M. Joëls, and F. Holsboer, "Stress and the brain: fromadaptation to disease, "Nature ReviewsNeuroscience, vol. 6, no. 6, pp. 463-475, 2005.
40. H. Anisman, "Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder, " Journal of Psychiatry & Neuroscience, vol. 34, no. 1, pp. 4-20, 2009.
41. A.-M. Myint and Y.-K. Kim, "Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis, " Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 48, pp. 304-313, 2014.
42. A. Neumeister, "Tryptophan depletion, serotonin, and depression: where do we stand?" Psychopharmacology Bulletin, vol. 37, no. 4, pp. 99-115, 2003.
43. S. Ali, M. A. Stone, J. L. Peters, M. J. Davies, and K. Khunti, "The prevalence of co-morbid depression in adults with Type 2 diabetes: A systematic review andmeta-analysis, " DiabeticMedicine, vol. 23, no. 11, pp. 1165-1173, 2006.
44. A. Nouwen, K. Winkley, J. Twisk et al., "Type 2 diabetes mellitus as a risk factor for the onset of depression: A systematic review and meta-analysis, " Diabetologia, vol. 53, no. 12, pp. 2480-2486, 2010.
45. A. Engum, A. Mykletun, K. Midthjell, A. Holen, and A. A. Dahl, "Depression and diabetes: A large population-based study of sociodemographic, lifestyle, and clinical factors associated with depression in type 1 and type 2 diabetes, " Diabetes Care, vol. 28, no. 8, pp. 1904-1909, 2005.
46. T. Claudi, W. Ingskog, J. G. Cooper, A. K. Jenum, and M. F. Hausken, "Quality of diabetes care in Norwegian general practice, " Tidsskrift for den Norske Laegeforening, vol. 128, no. 22, pp. 2570-2574, 2008.
47. R. Turner andUK Prospective Diabetes Study (UKPDS)Group, "Intensive blood-glucose controlwith sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), " The Lancet, vol. 352, no. 9131, pp. 837-853, 1998.
48. B. van Harten, F.-E. de Leeuw, H. C. Weinstein, P. Scheltens, and G. J. Biessels, "Brain imaging in patients with diabetes: A systematic review, " Diabetes Care, vol. 29, no. 11, pp. 2539-2548, 2006.
49. S. M. Gold, I. Dziobek, V. Sweat et al., "Hippocampal damage andmemory impairments as possible early brain complications of type 2 diabetes, " Diabetologia, vol. 50, no. 4, pp. 711-719, 2007.
50. G. Musen, K. L. In, C. R. Sparks et al., "Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry, " Diabetes, vol. 55, no. 2, pp. 326-333, 2006.
51. O. Ajilore, E. Haroon, S. Kumaran et al., "Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy, " Neuropsychopharmacology, vol. 32, no. 6, pp. 1224-1231, 2007.
52. O. Ajilore, K. Narr, J. Rosenthal et al., "Regional cortical gray matter thickness differences associated with type 2 diabetes andmajor depression, " Psychiatry Research-Neuroimaging, vol. 184, no. 2, pp. 63-70, 2010.
53. A. Kumar, R. Gupta, A. Thomas, O. Ajilore, and G. Hellemann, "Focal subcortical biophysical abnormalities in patients diagnosed with type 2 diabetes and depression, " Archives of General Psychiatry, vol. 66, no. 3, pp. 324-330, 2009.
54. R. I. G. Holt, D. I. W. Phillips, K. A. Jameson, C. Cooper, E. M. Dennison, and R. C. Peveler, "The relationship between depression and diabetes mellitus: findings from the Hertfordshire Cohort Study, " Diabetic Medicine, vol. 26, no. 6, pp. 641-648, 2009.
55. M. J. Knol, J. W. R. Twisk, A. T. F. Beekman, R. J. Heine, F. J. Snoek, and F. Pouwer, "Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis, " Diabetologia, vol. 49, no. 5, pp. 837-845, 2006.
56. F. Rotella and E. Mannucci, "Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies, " Diabetes Research and Clinical Practice, vol. 99, no. 2, pp. 98-104, 2013.
57. F. Rotella and E. Mannucci, "Depression as a risk factor for diabetes: A meta-analysis of longitudinal studies, " The Journal of Clinical Psychiatry, vol. 74, no. 1, pp. 31-37, 2013.
58. S. M. A. Asghar, A. Hussain, L. Diep, B. Bhowmik, and P. Thorsby, "Depression and insulin resistance in non-diabetic subjects: An intervention study with insulin clamp techniqe, " International Journal of Clinical Medicine, vol. 3, pp. 575-581, 2012.
59. K. Barnard, R. C. Peveler, and R. I. G. Holt, "Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation, " Diabetes Care, vol. 36, no. 10, pp. 3337-3345, 2013.
60. J. M. Yoon, E.-G. Cho, H.-K. Lee, and S. M. Park, "Antidepressant use and diabetes mellitus risk: A meta-analysis, " Korean Journal of Family Medicine, vol. 34, no. 4, pp. 228-240, 2013.
61. R. Isaac, S. Boura-Halfon, D. Gurevitch, A. Shainskaya, Y. Levkovitz, and Y. Zick, "Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic beta cells, " The Journal of Biological Chemistry, vol. 288, no. 8, pp. 5682-5693, 2013.
62. Y. Levkovitz, G. Ben-shushan, A. Hershkovitz et al., "Antidepressants induce cellular insulin resistance by activation of IRS-1 kinases, " Molecular and Cellular Neuroscience, vol. 36, no. 3, pp. 305-312, 2007.
63. R. Holliday, "Epigenetics: A historical overview, " Epigenetics, vol. 1, no. 2, pp. 76-80, 2006.
64. M. Jakovljevíc, ?Z. Reiner, D. Mili?cíc, and ?Z. Crn?cevíc, "Comorbidity, multimorbidity and personalized psychosomatic medicine: epigenetics rolling on the horizon, " Psychiatria Danubina, vol. 22, no. 2, pp. 184-189, 2010.
65. E. J. Nestler, "Epigenetic mechanisms of depression, " JAMA Psychiatry, vol. 71, no. 4, pp. 454-456, 2014.
66. T. Dayeh, P. Volkov, S. Salö et al. "Genome-wideDNAmethylation analysis of human pancreatic islets fromtype 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion, " PLoS Genetics vol. 10 no. 3 Artical ID e1004160 2014.
67. J. Wang, B. Gong, W. Zhao et al., "Epigenetic mechanisms linking diabetes and synaptic impairments, " Diabetes, vol. 63, no. 2, pp. 645-654, 2014.